European Archives - Page 1065 of 1615 - European Medical Journal

This site is intended for healthcare professionals

Continue
Secondary Hyperparathyroidism in Non dialysis Chronic Kidney Disease
7 Mins
20 Jul 2021

Secondary Hyperparathyroidism in Non-dialysis Chronic Kidney Disease

Chronic kidney disease can result in morbidity and mortality not only due to renal dysfunction itself, but also to associated…
Neph 9.1 Content Image
2 Mins
20 Jul 2021

Nephrotoxic Mechanisms of Gadolinium: Implications for the Use of Gadolinium-Based Contrast Agents

Gadolinium-based contrast agents are widely used for MRI. Although they may be considered well-tolerated at recommended dosing levels, recent evidence supports the deposition of free gadolinium in the tissues and its slow release into circulation, resulting in long-term toxicity, which is aggravated in renal patients.
5 Mins
20 Jul 2021

INTERVIEW: KENAR D. JHAVERI

Kenar D. Jhaveri | Professor of Medicine and Associate Chief in the Division of Kidney Diseases and Hypertension, Hofstra/Northwell School of Medicine, Hempstead, New York, USA
1 Mins
20 Jul 2021

‘Sweet Hypoxia’ with Acute Kidney Injury: The Unpredictability of Acute Hypoxic Respiratory Failure in COVID-19 Infection – a Community Hospital Experience

The authors revisited the phenomenon of asymptomatic patients despite very low pulse oximetry readings, the so-called ‘sweet hypoxia’, ‘happy hypoxia’, or ‘silent hypoxaemia’.
8 Mins
20 Jul 2021

Editor’s Pick: Blood Volume Monitoring: A Clinical Tool to Guide Ultrafiltration in Volume Control and Optimisation of Intradialytic Blood Pressure

The use of BVM dates back to the early 1990s when CRIT-LINE® technology (Fresenius Medical Care, Bad Homburg, Germany) was first used as a non-invasive method of measuring haematocrit changes during haemodialysis, in real time, by connection of an additional monitor to the dialysis arterial line set-up.
Neph 9.1 Content Image
9 Mins
20 Jul 2021

Idefirix® (Imlifidase): A Paradigm Shift in Transplanting the Untransplantable?

Imlifidase was granted a conditional marketing authorisation by the European Commission in August 2020 for “desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor.”36 This milestone launched a new era in kidney transplantation for selected patients who would previously have remained untreated.
3 Mins
20 Jul 2021

Innovations in Haemodialysis

THE ‘Innovations in Haemodialysis’ session of this year’s European Renal Association –European Dialysis and Transplant Association (ERA-EDTA) Virtual Congress 2021 focused on discussing important inclusions to the design and development of new haemodialysis (HD) therapies.
11 Mins
20 Jul 2021

Trace Elements and Chronic Kidney Disease: A Cross-Sectional Study from Jamaica

Trace elements are ubiquitous entities and a fair number of non-essential xenobiotics gain entry into the body via a multitude of ways, including through groundwater (arsenic, strontium, silicon), inhalation of silica dust (silicon), gasoline (lead), cigarette smoke, and soil (cadmium) and food contamination (arsenic, mercury).
FUTURE SCENARIOS FOR RENAL DISEASE ASSOCIATED WITH CLIMATE CHANGE
4 Mins
20 Jul 2021

Future Scenarios for Renal Disease Associated with Climate Change

One of the highlights of this year’s European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) congress, was the session on future scenarios for renal disease.
8 Mins
20 Jul 2021

INTERVIEW: ROBERT JOHN UNWIN

Interview with Robert John Unwin | Professor Emeritus of Nephrology, former Professor of Nephrology and Physiology, University College London, UK; Scientific Advisory Board member of ERA-EDTA
We’ve noticed you’re accessing
from North/South America.